ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,618,000 | -56.9% | 62,245 | -38.4% | 0.26% | -66.8% |
| Q3 2020 | $3,758,000 | -27.5% | 101,099 | -0.0% | 0.79% | -28.7% |
| Q2 2020 | $5,187,000 | +85.3% | 101,101 | +13.9% | 1.10% | +30.5% |
| Q1 2020 | $2,799,000 | -62.2% | 88,760 | -28.6% | 0.84% | -44.5% |
| Q4 2019 | $7,408,000 | +355.6% | 124,231 | +452.7% | 1.52% | +45.9% |
| Q1 2018 | $1,626,000 | +118.0% | 22,478 | +98.4% | 1.04% | +72.7% |
| Q4 2017 | $746,000 | +65.8% | 11,327 | +26.1% | 0.60% | +30.5% |
| Q3 2017 | $450,000 | -14.3% | 8,980 | -20.8% | 0.46% | -29.3% |
| Q2 2017 | $525,000 | – | 11,335 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |